S&P・Nasdaq 本質的価値 お問い合わせ

Esperion Therapeutics, Inc. ESPR NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$9.00
+314.7%

Esperion Therapeutics, Inc. (ESPR) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は BIOTECH TARGET N V 4,477,964 株保有. その他の主要保有者には DOMAIN PARTERS VII L P および Koenig Sheldon L..

過去12ヶ月間にインサイダーは 31 件の取引を実施 ESPR 株式 — 12 件の買い (評価額 $4.56M) および 17 件の売り (評価額 $502.95K). インサイダーの売りが買いを上回っています.

ESPR インサイダー保有状況

最大保有者
BIOTECH TARGET N V
4,477,964 株
買い(12ヶ月)
12
$4.56M 評価額
売り(12ヶ月)
17
$502.95K 評価額
12ヶ月取引活動
買い 39%
売り 55%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Biotech Target N V 10 Percent Owner 4,477,964 2021-05-26
100%
2 Domain Parters Vii L P 10 Percent Owner 2,216,935 2015-03-24
50%
3 Koenig Sheldon L. President and CEO 2,172,699 2026-03-18
49%
4 Aisling Capital Ii Lp 10 Percent Owner 1,904,594 2015-04-27
43%
5 Alta Partners Viii, L.p. 10 Percent Owner 1,709,967 2015-02-20
38%
6 Boxer Capital, Llc 10 Percent Owner 1,161,250 2018-11-05
26%
7 Halladay Benjamin Chief Financial Officer 713,602 2026-03-18
16%
8 Looker Benjamin Chief Legal Officer 679,348 2026-03-18
15%
9 Newton Roger S Director 548,726 2019-03-14
12%
10 Harlow John B. Jr. Chief Commercial Officer 380,000 2025-12-08
8%
11 Warren Eric Chief Commercial Officer 370,218 2025-04-21
8%
12 Foody Joanne M. Chief Medical Officer 272,862 2024-07-19
6%
13 Mayleben Timothy M President & CEO 175,000 2021-01-29
4%
14 Mcgowan Mary Chief Medical Officer 140,000 2017-02-22
3%
15 Vitullo Nicole Director 88,000 2025-06-02
2%
16 Woody Tracy M Director 88,000 2025-06-02
2%
17 Bartram Richard Chief Financial Officer 82,751 2022-03-16
2%
18 Fischer Seth H. Z. Director 44,000 2025-06-02
1%
19 Carroll J Martin Director 44,000 2025-06-02
1%
20 Shepard Jay Director 44,000 2025-06-02
1%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-03-17 Halladay Benjamin Chief Financial Officer 情報に基づく売り 6,424 $2.71 $17.38K
2026-03-17 Looker Benjamin Chief Legal Officer 情報に基づく売り 5,708 $2.70 $15.43K
2026-03-17 Koenig Sheldon L. President and CEO 情報に基づく売り 25,578 $2.72 $69.55K
2026-03-13 Halladay Benjamin Chief Financial Officer RSU 付与(制限付株式) 221,270 $2.44 $539.9K
2026-03-13 Looker Benjamin Chief Legal Officer RSU 付与(制限付株式) 269,230 $2.44 $656.92K
2026-03-13 Koenig Sheldon L. President and CEO RSU 付与(制限付株式) 647,460 $2.44 $1.58M
2026-01-20 Looker Benjamin General Counsel 情報に基づく売り 1,689 $2.88 $4.87K
2025-12-17 Halladay Benjamin Chief Financial Officer 情報に基づく売り 7,337 $3.67 $26.9K
2025-12-17 Looker Benjamin General Counsel 情報に基づく売り 6,517 $3.67 $23.9K
2025-12-17 Koenig Sheldon L. President and CEO 情報に基づく売り 48,244 $3.67 $177.2K
2025-12-04 Harlow John B. Jr. Chief Commercial Officer RSU 付与(制限付株式) 380,000 $3.79 $1.44M
2025-11-17 Harlow John B. Jr. Officer 不明 - - -
2025-09-17 Halladay Benjamin Chief Financial Officer 情報に基づく売り 7,046 $2.81 $19.79K
2025-09-17 Looker Benjamin General Counsel 情報に基づく売り 6,267 $2.80 $17.57K
2025-09-17 Koenig Sheldon L. President and CEO 情報に基づく売り 28,427 $2.79 $79.25K
2025-07-17 Halladay Benjamin Chief Financial Officer 情報に基づく売り 11 $1.12 $12.27
2025-07-17 Looker Benjamin General Counsel 情報に基づく売り 1,304 $1.13 $1.47K
2025-07-01 Thompson John Craig Director RSU 付与(制限付株式) 40,000 $1.00 $40K
2025-07-01 Thompson John Craig Director 不明 - - -
2025-06-17 Halladay Benjamin Chief Financial Officer 情報に基づく売り 7,229 $1.15 $8.33K
2025-06-17 Looker Benjamin General Counsel 情報に基づく売り 6,422 $1.15 $7.4K
2025-06-17 Koenig Sheldon L. President and CEO 情報に基づく売り 30,474 $1.11 $33.8K
2025-05-29 Woody Tracy M Director RSU 付与(制限付株式) 88,000 $0.87 $76.56K
2025-05-29 Shepard Jay Director RSU 付与(制限付株式) 44,000 $0.87 $38.28K
2025-05-29 Fischer Seth H. Z. Director RSU 付与(制限付株式) 44,000 $0.87 $38.28K
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る